Search

PerkinElmer Inc

Gesloten

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken

By Trading Economics

Inkomsten

13M

53M

Verkoop

19M

730M

K/W

Sectorgemiddelde

75.05

51.78

EPS

1.37

Dividendrendement

0.18

Winstmarge

7.329

Werknemers

11,000

EBITDA

8.8M

189M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+4.65% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.18%

1.96%

Volgende Winsten

1 feb 2027

Volgende dividenddatum

13 nov 2026

Volgende Ex Dividend datum

22 jan 2027

Marktinformatie

By TradingEconomics

Marktkapitalisatie

4.1B

17B

Vorige openingsprijs

0

Vorige sluitingsprijs

0

PerkinElmer Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 nov 2026, 21:05 UTC

News
Correlated Moves

Revvity, Inc. declines as JP Morgan, Barclays, and RBC Capital raise price targets to $160, $175, and $172, respectively, amid broader market conditions.

3 nov 2026, 23:06 UTC

Revvity, Inc. shares traded modestly lower in after-market hours on Tuesday, remaining above its 20-day moving average and near the upper end of its one-month range.

2 nov 2026, 23:31 UTC

In after-market trading, Revvity, Inc. has gained ground, recovering from earlier weakness to reach a peak just before the latest observation.

30 okt 2026, 21:51 UTC

News

Revvity, Inc. declared a quarterly dividend of $0.07 per share, payable on February 12, 2027, to shareholders of record as of January 22, 2027.

29 okt 2026, 20:07 UTC

Revvity, Inc. shares are advancing, marking nine consecutive days of higher closes and peaking significantly above Wednesday's close.

28 okt 2026, 20:06 UTC

Correlated Moves

Revvity, Inc. shares are advancing, continuing an upward trend since Tuesday, despite earlier pulling back from a session high, remaining above its 20-day moving average.

26 okt 2026, 19:16 UTC

Revvity Inc shares are advancing, continuing a trend of modest gains since Friday's close, despite an earlier pullback from a session high.

23 okt 2026, 20:13 UTC

Revvity Inc shares are trading modestly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher.

22 okt 2026, 21:41 UTC

Revvity Inc shares have declined in after-market trading, reaching their lowest point of the day after moving from a slight loss post-close.

21 okt 2026, 20:07 UTC

Correlated Moves

Revvity Inc shares are advancing, continuing an upward trend since Tuesday, while Charles River Laboratories is sharply higher with increased trading activity and volume.

20 okt 2026, 20:02 UTC

News

Revvity Inc. launches its AI-first Signals LabGistics solution to streamline scientific workflows in pharma and biotech, with positive outlook from Citrini Research.

19 okt 2026, 19:36 UTC

Correlated Moves

Revvity Inc shares are declining, facing speculation around Thermo Fisher Scientific Inc's upcoming earnings report, despite earlier reaching a session high.

16 okt 2026, 21:02 UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

15 okt 2026, 23:46 UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

14 okt 2026, 23:46 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

13 okt 2026, 20:13 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

12 okt 2026, 19:51 UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

8 okt 2026, 20:06 UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

7 okt 2026, 19:25 UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

6 okt 2026, 22:41 UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

5 okt 2026, 19:21 UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2 okt 2026, 19:45 UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

1 okt 2026, 20:03 UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

30 sep 2026, 21:02 UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

29 sep 2026, 19:36 UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

28 sep 2026, 20:20 UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

25 sep 2026, 20:01 UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

24 sep 2026, 23:11 UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

23 sep 2026, 20:07 UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

22 sep 2026, 19:31 UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

Peer Vergelijking

Prijswijziging

PerkinElmer Inc Prognose

Koersdoel

By TipRanks

4.65% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 166.846 USD  4.65%

Hoogste 190 USD

Laagste 120 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor PerkinElmer Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

6

Buy

9

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat